Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 27 Apr 2023
Treatment of Retinopathy of Prematurity with Biosimilar Ranibizumab Seems Effective.
Read Full NewsPrograms offering telehealth counseling and nicotine replacement products should be part of routine oncology care, researchers say.
Researchers evaluate minimal residual disease status in 128 adults with relapsed or refractory follicular lymphoma treated with epcoritamab.
A new study explores whether germline profiling could refine the subclassification and prognosis of therapy-related myeloid neoplasms beyond treatment history alone.
1.
Early PET May Help Tailor Therapy in Hodgkin Lymphoma
2.
PPI, Antibiotics May Curb Durvalumab Efficacy in NSCLC
3.
In leukemia, allogeneic HCT is beneficial following primary induction failure.
4.
Experts suggest Michelangelo depicted breast cancer in the Sistine Chapel fresco
5.
The acceptance of innovative hormonal therapy for advanced prostate cancer is racialized.
1.
Senescence in Cancer Therapy: Mechanisms, Clinical Relevance, and Therapeutic Implications
2.
What Is A High MCV Level? Causes, Symptoms, And Treatment Options
3.
Case Study: Personalized Medicine Based on Genetic Profiling in Oncology
4.
Cancer Survivorship in the Aging Population
5.
The Capmist DM: A Revolutionary Way to Combat Dry Mouth
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
2.
Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
4.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
5.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge